272 related articles for article (PubMed ID: 7053655)
21. Effect of previous nutritional status on the formation of cholesterol gallstones in the prairie dog.
Cohen BI; Mosbach EH; McSherry CK
Lipids; 1988 Aug; 23(8):798-803. PubMed ID: 3185113
[TBL] [Abstract][Full Text] [Related]
22. Hyodeoxycholic acid: a new approach to gallstone prevention.
McSherry CK; Mosbach EH; Cohen BI; Une M; Stenger RJ; Singhal AK
Am J Surg; 1985 Jan; 149(1):126-32. PubMed ID: 3970744
[TBL] [Abstract][Full Text] [Related]
23. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
Maudgal DP; Kupfer RM; Northfield TC
Gut; 1982 Apr; 23(4):280-4. PubMed ID: 7076005
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of gallstone formation by sphincterotomy in the prairie dog: reversal by atropine.
Hutton SW; Sievert CE; Vennes JA; Duane WC
Gastroenterology; 1982 Jun; 82(6):1308-13. PubMed ID: 7067954
[TBL] [Abstract][Full Text] [Related]
25. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.
Reuben A; Qureshi Y; Murphy GM; Dowling RH
Eur J Clin Invest; 1986 Apr; 16(2):133-42. PubMed ID: 3089808
[TBL] [Abstract][Full Text] [Related]
26. Increases in gallbladder prostaglandin synthesis before the formation of cholesterol gallstones.
LaMorte WW; Booker ML; Scott TE; Williams LF
Surgery; 1985 Sep; 98(3):445-51. PubMed ID: 4035566
[TBL] [Abstract][Full Text] [Related]
27. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet.
Amigo L; Quiñones V; Mardones P; Zanlungo S; Miquel JF; Nervi F; Rigotti A
Gastroenterology; 2000 Apr; 118(4):772-9. PubMed ID: 10734029
[TBL] [Abstract][Full Text] [Related]
28. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.
Barbara L; Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R
Digestion; 1976; 14(3):209-19. PubMed ID: 955328
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster model.
Pearlman BJ; Bonorris GG; Phillips MJ; Chung A; Vimadalal S; Marks JW; Schoenfield LJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):634-41. PubMed ID: 467920
[TBL] [Abstract][Full Text] [Related]
30. Dietary cholesterol affects chenodeoxycholic acid action on biliary lipids.
Coyne MJ; Bonorris GG; Chung A; Cove H; Schoenfield LJ
Gastroenterology; 1977 May; 72(5 Pt 1):927-31. PubMed ID: 849824
[TBL] [Abstract][Full Text] [Related]
31. Highlights of the meeting on prevention of gallstones.
Grundy SM; Kalser SC
Hepatology; 1987; 7(5):946-51. PubMed ID: 3308668
[No Abstract] [Full Text] [Related]
32. Effect of bile diversion and sphincterotomy on gallbladder muscle contractility and gallstone formation.
Li YF; Weisbrodt NW; Moody FG
Am J Surg; 1991 Jul; 162(1):31-5. PubMed ID: 2063966
[TBL] [Abstract][Full Text] [Related]
33. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
Iser JH; Dowling H; Mok HY; Bell GD
N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
[TBL] [Abstract][Full Text] [Related]
34. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
35. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
[TBL] [Abstract][Full Text] [Related]
36. Gallstones. The present and future of medical dissolution.
Pearlman BJ; Schoenfield LJ
Med Clin North Am; 1978 Jan; 62(1):87-105. PubMed ID: 414030
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of cholesterol gallstones formation.
Grundy SM
Semin Liver Dis; 1983 May; 3(2):97-111. PubMed ID: 6683429
[No Abstract] [Full Text] [Related]
38. Aspirin does not inhibit cholesterol cholelithiasis in two established animal models.
Cohen BI; Mosbach EH; Ayyad N; Yoshii M; McSherry CK
Gastroenterology; 1991 Oct; 101(4):1109-16. PubMed ID: 1843846
[TBL] [Abstract][Full Text] [Related]
39. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
[TBL] [Abstract][Full Text] [Related]
40. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice.
Wang DQ; Tazuma S
J Lipid Res; 2002 Nov; 43(11):1960-8. PubMed ID: 12401895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
